GOBEL Announces Formation of Corporate Advisory Board With Senior Healthcare Leaders

GOBEL Announces Formation of Corporate Advisory Board With Senior Healthcare Leaders

August 11, 2023 Sam M 0

GOBEL Announces Formation of Corporate Advisory Board With Senior Healthcare Leaders

GOBEL Announces Formation of Corporate Advisory Board With Senior Healthcare Leaders

ST. PETERSBURG, Fla., August 11, 2023 (Newswire.com)

GOBEL, the world’s leading consulting and technology firm exclusively serving healthcare philanthropy, …

The post GOBEL Announces Formation of Corporate Advisory Board With Senior Healthcare Leaders first appeared on Enrose Magazine.

The post GOBEL Announces Formation of Corporate Advisory Board With Senior Healthcare Leaders appeared first on IGP Beauty.

BillionToOne Publishes UNITY Fetal RhD and Fetal Antigen NIPT Clinical Validity Demonstrating >99.9% Accuracy

BillionToOne Publishes UNITY Fetal RhD and Fetal Antigen NIPT Clinical Validity Demonstrating >99.9% Accuracy

August 11, 2023 Sam M 0

BillionToOne Publishes UNITY Fetal RhD and Fetal Antigen NIPT Clinical Validity Demonstrating >99.9% Accuracy

BillionToOne Publishes UNITY Fetal RhD and Fetal Antigen NIPT Clinical Validity Demonstrating >99.9% Accuracy

In a clinical validation study published on Scientific Reports, UNITY RhD NIPT and Fetal antigen NIPT demonstrated 100% sensitivity, 100% specificity, 99.9% precision with 0.1% no-call rate across 3,921 NIPT assays.

The post BillionToOne Publishes UNITY Fetal RhD and Fetal Antigen NIPT Clinical Validity Demonstrating >99.9% Accuracy first appeared on Enrose Magazine.

The post BillionToOne Publishes UNITY Fetal RhD and Fetal Antigen NIPT Clinical Validity Demonstrating >99.9% Accuracy appeared first on IGP Beauty.

Imagene Launches ImageneOI Platform on Oracle Cloud Infrastructure to Democratize AI-Based Molecular Profiling in Oncology

Imagene Launches ImageneOI Platform on Oracle Cloud Infrastructure to Democratize AI-Based Molecular Profiling in Oncology

August 11, 2023 Sam M 0

Imagene Launches ImageneOI Platform on Oracle Cloud Infrastructure to Democratize AI-Based Molecular Profiling in Oncology

Imagene Launches ImageneOI Platform on Oracle Cloud Infrastructure to Democratize AI-Based Molecular Profiling in Oncology

The ImageneOI rapid AI-based biomarker profiling platform significantly improves lung cancer patient outcomes, as demonstrated by a recently published case report.

Imagene Launches ImageneOI Platform on Oracle Cloud Infrastructure to Democratize AI-Based Molecular Profiling in Oncology
ImageneOI Platform and Case Report

ImageneOI AI-based Molecular Profiling Platform on OCI, and the published case report of impacting patients’ lives.

Imagene, an emerging leader in AI-based precision oncology, is proud to announce the launch of the ImageneOI platform on Oracle Cloud Infrastructure (OCI). The innovative platform, supported by proven clinical benefits, sets a new paradigm in cancer diagnostics by enabling rapid AI-based molecular profiling from biopsy images alone, overcoming key barriers and limitations in current diagnostic processes. ImageneOI already proved its significant impact under research on treatment initiation and averting radiation for two cancer patients, as published in a recent case report in the Journal of Clinical Pathology.

“We’re confident in selecting Oracle as our cloud provider and are pleased to join forces with Oracle in our mission to make advanced technologies drive better patient care,” said Dean Bitan, co-founder and CEO of Imagene. “Oracle is not only delivering consistent, high-performance computing with widespread global reach, but its focus on the healthcare sector has played a crucial role in enabling us to bring this transformative service to the forefront of cancer diagnostics.”

For AI inference computation and to process data at scale, Imagene partnered with Oracle to run its ImageneOI platform on OCI and will take advantage of OCI Supercluster and OCI AI infrastructure technology. OCI’s cost-effective, high-performance computing enables the ImageneOI platform to offer rapid biomarker profiling and to deliver impressive performance of approximately two minutes from uploading a digitized biopsy image to receiving a biomarkers status report. 

“Saving lives is technology’s single most important use,” said Safra Catz, CEO of Oracle. “We are proud that Oracle’s highly performant and secure cloud infrastructure will help Imagene improve access to care, drive informed decisions, lower costs, and ultimately save lives.”

ImageneOI aligns with oncology clinical guidelines that emphasize the importance of obtaining molecular testing for actionable cancer biomarkers before initiating treatment. This breakthrough technology paves the way for improved and personalized cancer care. It facilitates informed decision-making for optimal treatment strategies by reducing turnaround times from weeks to minutes.

The platform transforms cancer diagnosis by addressing a significant gap in the current healthcare landscape. In the United States, approximately 80 percent of cancer patients choose to receive treatment in community settings. In addition, 64 percent of lung cancer patients, which is the deadliest cancer, do not receive the optimal treatment mostly due to biomarker testing-related challenges and limited access to comprehensive Next-Generation Sequencing (NGS). Up to 30 percent of tested patients do not receive guidelines-recommended biomarkers testing results prior to first-line therapy initiation. This accessibility issue and under-tested populations presents a major obstacle to effective cancer treatment.

The pressing need and demand for rapid and accurate cancer diagnosis pose a significant challenge in advancing precision oncology. This challenge is highlighted by the projected rise in cancer incidence, lengthy turnaround times, and issues with tissue inadequacy. The accessibility of the ImageneOI platform on OCI makes it an invaluable rapid molecular profiling resource for research institutions and medical centers globally.

In conjunction with the launch, Imagene is initiating an Early Access Research Program. Interested parties are encouraged to get in touch for more information at [email protected].

About Oracle:

Oracle offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. For more information about Oracle (NYSE: ORCL), please visit us at www.oracle.com.

About Imagene:

Imagene is an emerging leader in AI-based precision oncology. The company leverages AI to profile, within minutes, a broad range of cancer biomarkers from a digitized biopsy image alone, providing physicians with immediate oncology intelligence to ensure optimal treatment for all cancer patients. Visit imagene-ai.com 

Trademarks

Oracle, Java, MySQL and NetSuite are registered trademarks of Oracle Corporation. NetSuite was the first cloud company–ushering in the new era of cloud computing.

Contact Information:

Avital Rabani

Head of Marketing

[email protected]

Original Source:

Imagene Launches ImageneOI Platform on Oracle Cloud Infrastructure to Democratize AI-Based Molecular Profiling in Oncology

The post Imagene Launches ImageneOI Platform on Oracle Cloud Infrastructure to Democratize AI-Based Molecular Profiling in Oncology first appeared on Enrose Magazine.

The post Imagene Launches ImageneOI Platform on Oracle Cloud Infrastructure to Democratize AI-Based Molecular Profiling in Oncology appeared first on IGP Beauty.

Los Angeles Mission Helps Prepare Homeless Children to Start the New School Year at Its Third Annual Back-to-School Fair & Supply Giveaway
Dr. Marcus Robinson Joins C4 Consulting’s (Behavioral Health Business Consulting) Board of Directors

Dr. Marcus Robinson Joins C4 Consulting’s (Behavioral Health Business Consulting) Board of Directors

August 9, 2023 Sam M 0

Dr. Marcus Robinson Joins C4 Consulting’s (Behavioral Health Business Consulting) Board of Directors

Dr. Marcus Robinson Joins C4 Consulting’s (Behavioral Health Business Consulting) Board of Directors

Dr. Marcus Robinson’s Expertise and Passion for Community Development and Social Innovation Will Help C4 Grow the Impact of Businesses They Serve

Dr. Marcus Robinson Joins C4 Consulting’s (Behavioral Health Business Consulting) Board of Directors
Dr. Marcus Robinson Founder, Social Innovation Group

Dr. Marcus Robinson Joins C4 Consulting’s (Behavioral Health Business Consulting) Board of Directors

C4 Behavioral Health Consulting is honored to have Dr. Marcus Robinson join the company’s Board of Directors.

Dr. Marcus Robinson is a thought leader on the human ecology of belonging. He is a published author, nationally renowned speaker, and transformative leader in nonprofit management and community development. Dr. Robinson is a consultant and trainer in the field of diversity, equity, inclusion, and belonging. Through his extensive and impactful career, he has influenced many of the world’s leading companies, including Whirlpool Corporation, Xerox, Whirlpool Europe, Eastman Kodak Company, Honeywell Canada, General Dynamics, and SC Johnson Wax, among others. He has also counseled governmental entities, such as the City of Santa Barbara; the City of Rochester, NY; the League of Cities of California and the State of California. Dr. Robinson, currently serves as the Executive Director of Collaboraction Theatre Company, curating socially conscious theatre in Chicago, IL. His impact, values, and passion for social innovation and change are attuned with the mission of C4 Consulting

“C4 Consulting is poised to make considerable contributions to the body of work and praxis in the behavioral health space. This work aligns well with my commitment to personal transformation and wellness. I am excited to join C4 as a member of its board and help make a difference in this space. It’s a great way to contribute to society.” – Dr. Marcus Robinson, Founder – Social Innovation Group and C4 Consulting Board Member

“We are honored to have Dr. Robinson join our Board of Directors in stewardship of our organization. His wisdom, experience, understanding and passion for community development and social innovation will help guide us as we continue to grow the impact of the businesses we serve, and ultimately the communities our clients serve. We look forward to his guidance in our growth and the impact our service has for behavioral providers and their communities.” –  Jonathan P. De Carlo, CEO of C4 Consulting.

Members of the C4 Consulting team will be presenting at several industry events, including:

Cape Cod Symposium – September 7-9, 2023

Rocky Mountain Symposium – September 29 – October 1, 2023

PTACC Training Summit – October 6 – 9, 2023

East Coast Symposium – November 3-5, 2023

The Treatment Center Investment & Valuation Retreat – November 27-29, 2023

To learn more, contact Christopher Bennett at: [email protected] or 866-329-7170 extension 715.

Contact Information:

Christopher Bennett

C4 Consulting

[email protected]

866-329-7170

Original Source:

Dr. Marcus Robinson Joins C4 Consulting’s (Behavioral Health Business Consulting) Board of Directors

The post Dr. Marcus Robinson Joins C4 Consulting’s (Behavioral Health Business Consulting) Board of Directors first appeared on Enrose Magazine.

The post Dr. Marcus Robinson Joins C4 Consulting’s (Behavioral Health Business Consulting) Board of Directors appeared first on IGP Beauty.

Endear Health Announces M in New Funding From Optum Ventures, Blue Cross of Idaho, 8VC and Additional Strategic Partners

Endear Health Announces $8M in New Funding From Optum Ventures, Blue Cross of Idaho, 8VC and Additional Strategic Partners

August 9, 2023 Sam M 0

Endear Health Announces M in New Funding From Optum Ventures, Blue Cross of Idaho, 8VC and Additional Strategic Partners

Endear Health Announces M in New Funding From Optum Ventures, Blue Cross of Idaho, 8VC and Additional Strategic Partners

Endear Health is focused on reducing the hurdles older adults face while navigating an increasingly digital world through the development of innovative consumer-centric engagement solutions

The post Endear Health Announces $8M in New Funding From Optum Ventures, Blue Cross of Idaho, 8VC and Additional Strategic Partners first appeared on Enrose Magazine.

The post Endear Health Announces $8M in New Funding From Optum Ventures, Blue Cross of Idaho, 8VC and Additional Strategic Partners appeared first on IGP Beauty.

Curiteva Announces FDA Clearance of Pedicle & SI Navigation Instrument System

Curiteva Announces FDA Clearance of Pedicle & SI Navigation Instrument System

August 8, 2023 Sam M 0

Curiteva Announces FDA Clearance of Pedicle & SI Navigation Instrument System

Curiteva Announces FDA Clearance of Pedicle & SI Navigation Instrument System

Curiteva® Continues to Innovate by Adding a Navigation Instrument System to Complement Its Prodigy® Pedicle Screw System and SI-LUTION® Sacroiliac Joint Fusion Systems

The post Curiteva Announces FDA Clearance of Pedicle & SI Navigation Instrument System first appeared on Enrose Magazine.

The post Curiteva Announces FDA Clearance of Pedicle & SI Navigation Instrument System appeared first on IGP Beauty.

Dr. Mark Huh Recognized for His Teaching by University of Pennsylvania School of Dental Medicine
Accuhealth Introduces First Cellular-Enabled Peak Flow Meter

Accuhealth Introduces First Cellular-Enabled Peak Flow Meter

August 7, 2023 Sam M 0

Accuhealth Introduces First Cellular-Enabled Peak Flow Meter

Accuhealth Introduces First Cellular-Enabled Peak Flow Meter

Device Will Be Critical in Aiding Patients Suffering From COPD

Accuhealth Introduces First Cellular-Enabled Peak Flow Meter
Accuhealth

Accuhealth, the leader in Remote Care

Accuhealth, a leading provider of remote patient monitoring and chronic care management solutions, proudly announces the introduction of the world’s first cellular-connected peak flow meter (PFM). This transformative technology aims to revolutionize at-home healthcare management for individuals living with chronic obstructive pulmonary disease (COPD).

COPD is a widespread global health issue and the third leading cause of death worldwide, impacting more than 15 million Americans. This severe respiratory condition can dramatically reduce the affected individuals’ quality of life. Accuhealth is committed to making healthcare more accessible and providing tools that empower patients to monitor and manage their health more effectively.

PFMs are user-friendly devices that allow patients of any age to easily check their lung function in real time. While spirometers tend to be handled in a physician’s office due to their complexity, PFMs provide immediate feedback on any lung function changes. The PFM devised by Accuhealth utilizes cellular connectivity to securely record readings on the patient’s electronic health record, thus removing the need for manual data entry. The valuable data generated helps healthcare providers gain essential insights into their patient’s health and intervene in a timely manner when required, averting unnecessary hospital admission. The portability of the device further bolsters its ease of use.

The Global Initiatives for Chronic Obstructive Lung Disease (GOLD) guidelines recommend measuring forced expiratory volume (FEV1) by spirometer annually. Physicians already perform spirometry tests annually in their offices. Accuhealth’s PFM transmits daily FEV1 and peak expiratory flow (PEF) data points to physicians, and with its easy-to-use and plug-and-play device, patients with COPD are ensured proper care management through daily health monitoring and annual visits to physicians. 

This innovative COPD monitoring solution, in addition to Accuhealth’s existing cellular SpO2 meter and sleep and resting heart rate monitor, allows Accuhealth to extend its services to an additional 15 million Americans.

Stephen Samson, CEO of Accuhealth, celebrates the release of this cutting-edge device, stating, “On our 5th anniversary, we are proud to unveil a groundbreaking device, heralding a significant step forward in our quest to make healthcare more accessible, effective, and impactful. The user-focused design of our cellular-connected peak flow meter allows patients to measure, monitor, and manage their respiratory health effortlessly.”

Samson further notes, “Accuhealth now offers a comprehensive, cellular, user-friendly solution catering to all chronic diseases, including but not limited to COPD, diabetes, congestive heart failure, kidney disease, and hypertension. Our research showed that older COPD patients often struggle with using a spirometer, leading to skipped readings. With our PFM that’s as easy to use as exhaling, we see improved patient adherence to ongoing health monitoring routines. Supported by a world-class care management team fluent in over 300 languages and devices operational in 191 countries, Accuhealth stands as the sole globally ready RPM provider.”

Accuhealth empowers physicians with the right data to stay ahead of negative health outcomes to keep patients healthy, happy, and out of the hospital. Founded in 2018, Accuhealth is a leading healthcare technology provider of turn-key remote patient monitoring solutions worldwide, providing hardware, software, and first-line 24/7/365 clinical monitoring to physicians with near real-time vital information and AI-enhanced data. Accuhealth’s touchpoints-as-a-service yields improved outcomes, increased patient satisfaction, reduced costs for payers, and increased revenue for clinics, setting a new standard of care. Remote patient monitoring and chronic care management made easy and done right. Visit www.accuhealth.tech for more information.

Contact Information:

Carla McCormick

PR Coordinator, Accuhealth

[email protected]

(213) 270-1175

Related Images


Accuhealth

Accuhealth

Accuhealth, the leader in Remote Care


Tellihealth Peak Flow Meter

Tellihealth Peak Flow Meter

Tellihealth’s world’s first peak flow meter

Original Source:

Accuhealth Introduces First Cellular-Enabled Peak Flow Meter

The post Accuhealth Introduces First Cellular-Enabled Peak Flow Meter first appeared on Enrose Magazine.

The post Accuhealth Introduces First Cellular-Enabled Peak Flow Meter appeared first on IGP Beauty.

Accuhealth Introduces First Cellular-Enabled Peak Flow Meter

Accuhealth Introduces First Cellular-Enabled Peak Flow Meter

August 7, 2023 Sam M 0

Accuhealth Introduces First Cellular-Enabled Peak Flow Meter

Accuhealth Introduces First Cellular-Enabled Peak Flow Meter

Device Will Be Critical in Aiding Patients Suffering From COPD

Accuhealth Introduces First Cellular-Enabled Peak Flow Meter
Accuhealth

Accuhealth, the leader in Remote Care

Accuhealth, a leading provider of remote patient monitoring and chronic care management solutions, proudly announces the introduction of the world’s first cellular-connected peak flow meter (PFM). This transformative technology aims to revolutionize at-home healthcare management for individuals living with chronic obstructive pulmonary disease (COPD).

COPD is a widespread global health issue and the third leading cause of death worldwide, impacting more than 15 million Americans. This severe respiratory condition can dramatically reduce the affected individuals’ quality of life. Accuhealth is committed to making healthcare more accessible and providing tools that empower patients to monitor and manage their health more effectively.

PFMs are user-friendly devices that allow patients of any age to easily check their lung function in real time. While spirometers tend to be handled in a physician’s office due to their complexity, PFMs provide immediate feedback on any lung function changes. The PFM devised by Accuhealth utilizes cellular connectivity to securely record readings on the patient’s electronic health record, thus removing the need for manual data entry. The valuable data generated helps healthcare providers gain essential insights into their patient’s health and intervene in a timely manner when required, averting unnecessary hospital admission. The portability of the device further bolsters its ease of use.

The Global Initiatives for Chronic Obstructive Lung Disease (GOLD) guidelines recommend measuring forced expiratory volume (FEV1) by spirometer annually. Physicians already perform spirometry tests annually in their offices. Accuhealth’s PFM transmits daily FEV1 and peak expiratory flow (PEF) data points to physicians, and with its easy-to-use and plug-and-play device, patients with COPD are ensured proper care management through daily health monitoring and annual visits to physicians. 

This innovative COPD monitoring solution, in addition to Accuhealth’s existing cellular SpO2 meter and sleep and resting heart rate monitor, allows Accuhealth to extend its services to an additional 15 million Americans.

Stephen Samson, CEO of Accuhealth, celebrates the release of this cutting-edge device, stating, “On our 5th anniversary, we are proud to unveil a groundbreaking device, heralding a significant step forward in our quest to make healthcare more accessible, effective, and impactful. The user-focused design of our cellular-connected peak flow meter allows patients to measure, monitor, and manage their respiratory health effortlessly.”

Samson further notes, “Accuhealth now offers a comprehensive, cellular, user-friendly solution catering to all chronic diseases, including but not limited to COPD, diabetes, congestive heart failure, kidney disease, and hypertension. Our research showed that older COPD patients often struggle with using a spirometer, leading to skipped readings. With our PFM that’s as easy to use as exhaling, we see improved patient adherence to ongoing health monitoring routines. Supported by a world-class care management team fluent in over 300 languages and devices operational in 191 countries, Accuhealth stands as the sole globally ready RPM provider.”

Accuhealth empowers physicians with the right data to stay ahead of negative health outcomes to keep patients healthy, happy, and out of the hospital. Founded in 2018, Accuhealth is a leading healthcare technology provider of turn-key remote patient monitoring solutions worldwide, providing hardware, software, and first-line 24/7/365 clinical monitoring to physicians with near real-time vital information and AI-enhanced data. Accuhealth’s touchpoints-as-a-service yields improved outcomes, increased patient satisfaction, reduced costs for payers, and increased revenue for clinics, setting a new standard of care. Remote patient monitoring and chronic care management made easy and done right. Visit www.accuhealth.tech for more information.

Contact Information:

Carla McCormick

PR Coordinator, Accuhealth

[email protected]

(213) 270-1175

Related Images


Accuhealth

Accuhealth

Accuhealth, the leader in Remote Care


Tellihealth Peak Flow Meter

Tellihealth Peak Flow Meter

Tellihealth’s world’s first peak flow meter

Original Source:

Accuhealth Introduces First Cellular-Enabled Peak Flow Meter

The post Accuhealth Introduces First Cellular-Enabled Peak Flow Meter first appeared on Enrose Magazine.

The post Accuhealth Introduces First Cellular-Enabled Peak Flow Meter appeared first on IGP Beauty.